Long
$MDR Is A Speculative Buy Above $2.24

A lot will depend on news and the progress
McDermott (NYSE:MDR) is exploring strategic alternatives for its Lummus Technology unit, which it values at ~$2.5B, after receiving unsolicited approaches to acquire all or part of the business.
Lummus is a licensor of proprietary petrochemicals, refining, gasification and gas processing technologies.
MDR says it has hired Evercore as the lead advisor on the strategic alternatives process for Lummus.
MDR shares have plummeted on bankruptcy fears.
As always, trade with caution and use protective stops.
Good luck to all!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.